MORGAN STANLEY PLC/PUT/ABBOTT LABORATORIES/90/0.1/17.01.25 Share Price

Warrant

DE000ME1QQD3

Market Closed - Börse Stuttgart 20:13:41 05/07/2024 BST
0.192 EUR +3.78% Intraday chart for MORGAN STANLEY PLC/PUT/ABBOTT LABORATORIES/90/0.1/17.01.25
Current month+12.28%
1 month-1.54%
Date Price Change
05/07/24 0.192 +3.78%
04/07/24 0.185 -7.96%
03/07/24 0.201 +7.49%
02/07/24 0.187 +2.75%
01/07/24 0.182 +6.43%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 08:13 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying ABBOTT LABORATORIES
Issuer Morgan Stanley
WKN ME1QQD
ISINDE000ME1QQD3
Date issued 06/10/2023
Strike 90 $
Maturity 17/01/2025 (195 Days)
Parity 10 : 1
Emission price 0.82
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.87
Lowest since issue 0.13
Spread 0.003
Spread %1.63%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104 USD
Average target price
124.9 USD
Spread / Average Target
+20.09%
Consensus